2023-2029 Global Dermatomyositis Treatment Industry Research & Trends Analysis Report
2023-2029 Global Dermatomyositis Treatment Industry Research & Trends Analysis Report
Get latest Market Research Reports on Dermatomyositis Treatment. Industry analysis and Market Report on Dermatomyositis Treatment is a syndicated market report, published as Global Dermatomyositis Treatment Market Research Report . It is complete Research Study and Industry Analysis of Dermatomyositis Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Study, the global market for Dermatomyositis Treatment should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Dermatomyositis Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Dermatomyositis Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Immunosuppressants segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Dermatomyositis Treatment include Novartis AG, Endo International Inc, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Cipla Inc, Dr Reddy's Laboratories Ltd, Abbott, F. Hoffmann -La Roche Ltd and Pfizer Inc, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Dermatomyositis is a rare inflammatory skin disorders that is typically characterized by muscle weakness and a severe skin rash. It is mainly caused by either viral infection of the tissues of skeletal muscle or autoimmune reaction. Symptoms may vary broadly from patient to patient. Deformities in the muscles may initiate with weakness and pain in the muscles of the thighs, the hips, the upper arms, and the trunk. The muscles may become sore, tender, and stiff and eventually express signs of degeneration.
This report aims to provide a comprehensive study of the global market for Dermatomyositis Treatment. Report Highlights:
(1) Global Dermatomyositis Treatment market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Dermatomyositis Treatment market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Dermatomyositis Treatment market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Dermatomyositis Treatment segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Dermatomyositis Treatment segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Dermatomyositis Treatment, capacity, production and trends.
(7) Dermatomyositis Treatment industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Immunosuppressants
Glucocorticoids
Market segment by application, can be divided into
Hospital
Specialty Clinic
Other
Market segment by players, this report covers
Novartis AG
Endo International Inc
Teva Pharmaceutical Industries Ltd
Glenmark Pharmaceuticals Ltd
Cipla Inc
Dr Reddy's Laboratories Ltd
Abbott
F. Hoffmann -La Roche Ltd
Pfizer Inc
Zydus Group
Lupin
Amorphex Therapeutics Holdings, Inc
Bausch Health Companies Inc
1 Market Overview
1.1 Dermatomyositis Treatment Definition
1.2 Global Dermatomyositis Treatment Market Size and Forecast
1.2.1 By Revenue, Global Dermatomyositis Treatment Market Size, 2018-2029
1.2.2 By Sales Volume, Global Dermatomyositis Treatment Market Size, 2018-2029
1.2.3 Global Dermatomyositis Treatment Price Trend, 2018-2029
1.3 China Dermatomyositis Treatment Market Size and Forecast
1.3.1 By Revenue, China Dermatomyositis Treatment Market Size, 2018-2029
1.3.2 By Sales Volume, China Dermatomyositis Treatment Market Size, 2018-2029
1.3.3 China Dermatomyositis Treatment Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Dermatomyositis Treatment Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Dermatomyositis Treatment Share in Global Market, 2018-2029
1.4.3 Dermatomyositis Treatment Market Size: China VS Global, 2018-2029
1.5 Dermatomyositis Treatment Market Dynamics
1.5.1 Dermatomyositis Treatment Market Drivers
1.5.2 Dermatomyositis Treatment Market Restraints
1.5.3 Dermatomyositis Treatment Industry Trends
1.5.4 Dermatomyositis Treatment Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Dermatomyositis Treatment Revenue by Company, 2018-2023
2.2 Global Dermatomyositis Treatment Sales Volume by Company, 2018-2023
2.3 Global Dermatomyositis Treatment Price by Company, 2018-2023
2.4 Global Dermatomyositis Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Dermatomyositis Treatment Concentration Ratio
2.6 Global Dermatomyositis Treatment Mergers & Acquisitions, Expansion Plans
2.7 Global Dermatomyositis Treatment Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Dermatomyositis Treatment Revenue by Company, 2018-2023
3.2 China Dermatomyositis Treatment Sales Volume by Company, 2018-2023
3.3 China Dermatomyositis Treatment Dermatomyositis Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Dermatomyositis Treatment Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Dermatomyositis Treatment Domestic VS Export
3.6 China Market, Dermatomyositis Treatment Import & Export
3.6.1 China Market, Dermatomyositis Treatment Import & Export, 2018-2029
3.6.2 China Dermatomyositis Treatment Import & Export Trends
3.6.3 Main Sources of China Dermatomyositis Treatment Import
3.6.4 Export Destination of China Dermatomyositis Treatment
4 Dermatomyositis Treatment Production by Region
4.1 Global Dermatomyositis Treatment Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Dermatomyositis Treatment Manufacturers
4.3 Global Major Manufacturers, Dermatomyositis Treatment Capacity Expansion and Future Plans
4.4 Global Dermatomyositis Treatment Capacity by Region
4.5 Global Dermatomyositis Treatment Production by Region
4.5.1 Global Dermatomyositis Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Dermatomyositis Treatment Production by Region, 2018-2023
4.5.3 Global Dermatomyositis Treatment Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Dermatomyositis Treatment Industry Chain
5.2 Dermatomyositis Treatment Upstream Analysis
5.2.1 Dermatomyositis Treatment Core Raw Materials
5.2.2 Main Manufacturers of Dermatomyositis Treatment Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Dermatomyositis Treatment Production Mode
5.6 Dermatomyositis Treatment Procurement Model
5.7 Dermatomyositis Treatment Industry Sales Model and Sales Channels
5.7.1 Dermatomyositis Treatment Sales Model
5.7.2 Dermatomyositis Treatment Typical Distributors
6 Sights by Type
6.1 Dermatomyositis Treatment Classification
6.1.1 Immunosuppressants
6.1.2 Glucocorticoids
6.2 By Type, Global Dermatomyositis Treatment Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Dermatomyositis Treatment Revenue, 2018-2029
6.4 By Type, Global Dermatomyositis Treatment Sales Volume, 2018-2029
6.5 By Type, Global Dermatomyositis Treatment Price, 2018-2029
7 Sights by Application
7.1 Dermatomyositis Treatment Segment by Application
7.1.1 Hospital
7.1.2 Specialty Clinic
7.1.3 Other
7.2 By Application, Global Dermatomyositis Treatment Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Dermatomyositis Treatment Revenue, 2018-2029
7.4 By Application, Global Dermatomyositis Treatment Sales Volume, 2018-2029
7.5 By Application, Global Dermatomyositis Treatment Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Dermatomyositis Treatment Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Dermatomyositis Treatment Revenue, 2018-2029
8.3 By Region, Global Dermatomyositis Treatment Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Dermatomyositis Treatment Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Dermatomyositis Treatment Market Size Market Share
8.5 Europe
8.5.1 Europe Dermatomyositis Treatment Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Dermatomyositis Treatment Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Dermatomyositis Treatment Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Dermatomyositis Treatment Market Size Market Share
8.7 South America
8.7.1 South America Dermatomyositis Treatment Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Dermatomyositis Treatment Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Dermatomyositis Treatment Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Dermatomyositis Treatment Revenue, 2018-2029
9.3 By Country, Global Dermatomyositis Treatment Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Dermatomyositis Treatment Market Size, 2018-2029
9.4.2 By Company, U.S. Dermatomyositis Treatment Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Dermatomyositis Treatment Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Dermatomyositis Treatment Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Dermatomyositis Treatment Market Size, 2018-2029
9.5.2 By Company, Europe Dermatomyositis Treatment Sales Volume Market Share, 2022
9.5.3 By Type, Europe Dermatomyositis Treatment Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Dermatomyositis Treatment Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Dermatomyositis Treatment Market Size, 2018-2029
9.6.2 By Company, China Dermatomyositis Treatment Sales Volume Market Share, 2022
9.6.3 By Type, China Dermatomyositis Treatment Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Dermatomyositis Treatment Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Dermatomyositis Treatment Market Size, 2018-2029
9.7.2 By Company, Japan Dermatomyositis Treatment Sales Volume Market Share, 2022
9.7.3 By Type, Japan Dermatomyositis Treatment Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Dermatomyositis Treatment Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Dermatomyositis Treatment Market Size, 2018-2029
9.8.2 By Company, South Korea Dermatomyositis Treatment Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Dermatomyositis Treatment Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Dermatomyositis Treatment Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Dermatomyositis Treatment Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Dermatomyositis Treatment Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Dermatomyositis Treatment Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Dermatomyositis Treatment Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Dermatomyositis Treatment Market Size, 2018-2029
9.10.2 By Company, India Dermatomyositis Treatment Sales Volume Market Share, 2022
9.10.3 By Type, India Dermatomyositis Treatment Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Dermatomyositis Treatment Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Dermatomyositis Treatment Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Dermatomyositis Treatment Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Dermatomyositis Treatment Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Dermatomyositis Treatment Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Novartis AG
10.1.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
10.1.2 Novartis AG Dermatomyositis Treatment Models, Specifications and Application
10.1.3 Novartis AG Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Novartis AG Company Profile and Main Business
10.1.5 Novartis AG Recent Developments
10.2 Endo International Inc
10.2.1 Endo International Inc Company Information, Head Office, Market Area and Industry Position
10.2.2 Endo International Inc Dermatomyositis Treatment Models, Specifications and Application
10.2.3 Endo International Inc Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Endo International Inc Company Profile and Main Business
10.2.5 Endo International Inc Recent Developments
10.3 Teva Pharmaceutical Industries Ltd
10.3.1 Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
10.3.2 Teva Pharmaceutical Industries Ltd Dermatomyositis Treatment Models, Specifications and Application
10.3.3 Teva Pharmaceutical Industries Ltd Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Teva Pharmaceutical Industries Ltd Company Profile and Main Business
10.3.5 Teva Pharmaceutical Industries Ltd Recent Developments
10.4 Glenmark Pharmaceuticals Ltd
10.4.1 Glenmark Pharmaceuticals Ltd Company Information, Head Office, Market Area and Industry Position
10.4.2 Glenmark Pharmaceuticals Ltd Dermatomyositis Treatment Models, Specifications and Application
10.4.3 Glenmark Pharmaceuticals Ltd Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Glenmark Pharmaceuticals Ltd Company Profile and Main Business
10.4.5 Glenmark Pharmaceuticals Ltd Recent Developments
10.5 Cipla Inc
10.5.1 Cipla Inc Company Information, Head Office, Market Area and Industry Position
10.5.2 Cipla Inc Dermatomyositis Treatment Models, Specifications and Application
10.5.3 Cipla Inc Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Cipla Inc Company Profile and Main Business
10.5.5 Cipla Inc Recent Developments
10.6 Dr Reddy's Laboratories Ltd
10.6.1 Dr Reddy's Laboratories Ltd Company Information, Head Office, Market Area and Industry Position
10.6.2 Dr Reddy's Laboratories Ltd Dermatomyositis Treatment Models, Specifications and Application
10.6.3 Dr Reddy's Laboratories Ltd Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Dr Reddy's Laboratories Ltd Company Profile and Main Business
10.6.5 Dr Reddy's Laboratories Ltd Recent Developments
10.7 Abbott
10.7.1 Abbott Company Information, Head Office, Market Area and Industry Position
10.7.2 Abbott Dermatomyositis Treatment Models, Specifications and Application
10.7.3 Abbott Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Abbott Company Profile and Main Business
10.7.5 Abbott Recent Developments
10.8 F. Hoffmann -La Roche Ltd
10.8.1 F. Hoffmann -La Roche Ltd Company Information, Head Office, Market Area and Industry Position
10.8.2 F. Hoffmann -La Roche Ltd Dermatomyositis Treatment Models, Specifications and Application
10.8.3 F. Hoffmann -La Roche Ltd Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 F. Hoffmann -La Roche Ltd Company Profile and Main Business
10.8.5 F. Hoffmann -La Roche Ltd Recent Developments
10.9 Pfizer Inc
10.9.1 Pfizer Inc Company Information, Head Office, Market Area and Industry Position
10.9.2 Pfizer Inc Dermatomyositis Treatment Models, Specifications and Application
10.9.3 Pfizer Inc Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Pfizer Inc Company Profile and Main Business
10.9.5 Pfizer Inc Recent Developments
10.10 Zydus Group
10.10.1 Zydus Group Company Information, Head Office, Market Area and Industry Position
10.10.2 Zydus Group Dermatomyositis Treatment Models, Specifications and Application
10.10.3 Zydus Group Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Zydus Group Company Profile and Main Business
10.10.5 Zydus Group Recent Developments
10.11 Lupin
10.11.1 Lupin Company Information, Head Office, Market Area and Industry Position
10.11.2 Lupin Dermatomyositis Treatment Models, Specifications and Application
10.11.3 Lupin Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Lupin Company Profile and Main Business
10.11.5 Lupin Recent Developments
10.12 Amorphex Therapeutics Holdings, Inc
10.12.1 Amorphex Therapeutics Holdings, Inc Company Information, Head Office, Market Area and Industry Position
10.12.2 Amorphex Therapeutics Holdings, Inc Dermatomyositis Treatment Models, Specifications and Application
10.12.3 Amorphex Therapeutics Holdings, Inc Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Amorphex Therapeutics Holdings, Inc Company Profile and Main Business
10.12.5 Amorphex Therapeutics Holdings, Inc Recent Developments
10.13 Bausch Health Companies Inc
10.13.1 Bausch Health Companies Inc Company Information, Head Office, Market Area and Industry Position
10.13.2 Bausch Health Companies Inc Dermatomyositis Treatment Models, Specifications and Application
10.13.3 Bausch Health Companies Inc Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Bausch Health Companies Inc Company Profile and Main Business
10.13.5 Bausch Health Companies Inc Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Dermatomyositis Treatment Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Dermatomyositis Treatment Market Restraints
Table 3. Dermatomyositis Treatment Market Trends
Table 4. Dermatomyositis Treatment Industry Policy
Table 5. Global Dermatomyositis Treatment Revenue by Company, 2018-2023, US$ million
Table 6. Global Dermatomyositis Treatment Revenue Market Share by Company, 2018-2023
Table 7. Global Dermatomyositis Treatment Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Dermatomyositis Treatment Sales Volume Market Share by Company, 2018-2023
Table 9. Global Dermatomyositis Treatment Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Dermatomyositis Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Dermatomyositis Treatment Mergers & Acquisitions, Expansion Plans
Table 12. Global Dermatomyositis Treatment Manufacturers Product Type
Table 13. China Dermatomyositis Treatment Revenue by Company, 2018-2023, US$ million
Table 14. China Dermatomyositis Treatment Revenue Market Share by Company, 2018-2023
Table 15. China Dermatomyositis Treatment Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Dermatomyositis Treatment Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Dermatomyositis Treatment Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Dermatomyositis Treatment Import & Export Trends
Table 19. Main Sources of China Dermatomyositis Treatment Import
Table 20. Export Destination of China Dermatomyositis Treatment
Table 21. Global Headquarters and Manufacturing Base of Dermatomyositis Treatment Manufacturers
Table 22. Global Major Manufacturers, Dermatomyositis Treatment Capacity Expansion and Future Plans
Table 23. Global Dermatomyositis Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Dermatomyositis Treatment Production by Region, 2018-2023, (K Units)
Table 25. Global Dermatomyositis Treatment Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Dermatomyositis Treatment Upstream (Raw Materials)
Table 27. Global Dermatomyositis Treatment Typical Customers
Table 28. Dermatomyositis Treatment Typical Distributors
Table 29. By Type, Global Dermatomyositis Treatment Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Dermatomyositis Treatment Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Dermatomyositis Treatment Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Dermatomyositis Treatment Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Dermatomyositis Treatment Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Dermatomyositis Treatment Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Dermatomyositis Treatment Revenue Market Share, 2018-2029
Table 37. By Country, Global Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Dermatomyositis Treatment Sales Volume Market Share, 2018-2029
Table 39. Novartis AG Company Information, Head Office, Market Area and Industry Position
Table 40. Novartis AG Dermatomyositis Treatment Models, Specifications and Application
Table 41. Novartis AG Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Novartis AG Company Profile and Main Business
Table 43. Novartis AG Recent Developments
Table 44. Endo International Inc Company Information, Head Office, Market Area and Industry Position
Table 45. Endo International Inc Dermatomyositis Treatment Models, Specifications and Application
Table 46. Endo International Inc Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Endo International Inc Company Profile and Main Business
Table 48. Endo International Inc Recent Developments
Table 49. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
Table 50. Teva Pharmaceutical Industries Ltd Dermatomyositis Treatment Models, Specifications and Application
Table 51. Teva Pharmaceutical Industries Ltd Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Teva Pharmaceutical Industries Ltd Company Profile and Main Business
Table 53. Teva Pharmaceutical Industries Ltd Recent Developments
Table 54. Glenmark Pharmaceuticals Ltd Company Information, Head Office, Market Area and Industry Position
Table 55. Glenmark Pharmaceuticals Ltd Dermatomyositis Treatment Models, Specifications and Application
Table 56. Glenmark Pharmaceuticals Ltd Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Glenmark Pharmaceuticals Ltd Company Profile and Main Business
Table 58. Glenmark Pharmaceuticals Ltd Recent Developments
Table 59. Cipla Inc Company Information, Head Office, Market Area and Industry Position
Table 60. Cipla Inc Dermatomyositis Treatment Models, Specifications and Application
Table 61. Cipla Inc Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Cipla Inc Company Profile and Main Business
Table 63. Cipla Inc Recent Developments
Table 64. Dr Reddy's Laboratories Ltd Company Information, Head Office, Market Area and Industry Position
Table 65. Dr Reddy's Laboratories Ltd Dermatomyositis Treatment Models, Specifications and Application
Table 66. Dr Reddy's Laboratories Ltd Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Dr Reddy's Laboratories Ltd Company Profile and Main Business
Table 68. Dr Reddy's Laboratories Ltd Recent Developments
Table 69. Abbott Company Information, Head Office, Market Area and Industry Position
Table 70. Abbott Dermatomyositis Treatment Models, Specifications and Application
Table 71. Abbott Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Abbott Company Profile and Main Business
Table 73. Abbott Recent Developments
Table 74. F. Hoffmann -La Roche Ltd Company Information, Head Office, Market Area and Industry Position
Table 75. F. Hoffmann -La Roche Ltd Dermatomyositis Treatment Models, Specifications and Application
Table 76. F. Hoffmann -La Roche Ltd Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. F. Hoffmann -La Roche Ltd Company Profile and Main Business
Table 78. F. Hoffmann -La Roche Ltd Recent Developments
Table 79. Pfizer Inc Company Information, Head Office, Market Area and Industry Position
Table 80. Pfizer Inc Dermatomyositis Treatment Models, Specifications and Application
Table 81. Pfizer Inc Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Pfizer Inc Company Profile and Main Business
Table 83. Pfizer Inc Recent Developments
Table 84. Zydus Group Company Information, Head Office, Market Area and Industry Position
Table 85. Zydus Group Dermatomyositis Treatment Models, Specifications and Application
Table 86. Zydus Group Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Zydus Group Company Profile and Main Business
Table 88. Zydus Group Recent Developments
Table 89. Lupin Company Information, Head Office, Market Area and Industry Position
Table 90. Lupin Dermatomyositis Treatment Models, Specifications and Application
Table 91. Lupin Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Lupin Company Profile and Main Business
Table 93. Lupin Recent Developments
Table 94. Amorphex Therapeutics Holdings, Inc Company Information, Head Office, Market Area and Industry Position
Table 95. Amorphex Therapeutics Holdings, Inc Dermatomyositis Treatment Models, Specifications and Application
Table 96. Amorphex Therapeutics Holdings, Inc Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Amorphex Therapeutics Holdings, Inc Company Profile and Main Business
Table 98. Amorphex Therapeutics Holdings, Inc Recent Developments
Table 99. Bausch Health Companies Inc Company Information, Head Office, Market Area and Industry Position
Table 100. Bausch Health Companies Inc Dermatomyositis Treatment Models, Specifications and Application
Table 101. Bausch Health Companies Inc Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Bausch Health Companies Inc Company Profile and Main Business
Table 103. Bausch Health Companies Inc Recent Developments
List of Figure
Figure 1. Dermatomyositis Treatment Picture
Figure 2. By Revenue, Global Dermatomyositis Treatment Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Dermatomyositis Treatment Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Dermatomyositis Treatment Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Dermatomyositis Treatment Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Dermatomyositis Treatment Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Dermatomyositis Treatment Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Dermatomyositis Treatment Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Dermatomyositis Treatment Share of Global Market, 2018-2029
Figure 10. Global Dermatomyositis Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Dermatomyositis Treatment Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Dermatomyositis Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Dermatomyositis Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Dermatomyositis Treatment Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Dermatomyositis Treatment Domestic VS Export, 2022
Figure 16. Global Dermatomyositis Treatment Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Dermatomyositis Treatment Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Dermatomyositis Treatment Production Market Share & Forecast by Region, 2018-2029
Figure 19. Dermatomyositis Treatment Industry Chain
Figure 20. Dermatomyositis Treatment Procurement Model
Figure 21. Dermatomyositis Treatment Sales Model
Figure 22. Dermatomyositis Treatment Sales Channels, Direct Sales and Distribution
Figure 23. Immunosuppressants
Figure 24. Glucocorticoids
Figure 25. By Type, Global Dermatomyositis Treatment Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global Dermatomyositis Treatment Revenue Market Share, 2018-2029
Figure 27. By Type, Global Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)
Figure 28. By Type, Global Dermatomyositis Treatment Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global Dermatomyositis Treatment Price, 2018-2029, (US$/Unit)
Figure 30. Hospital
Figure 31. Specialty Clinic
Figure 32. Other
Figure 33. By Application, Global Dermatomyositis Treatment Revenue, 2018-2029, US$ Million
Figure 34. By Application, Global Dermatomyositis Treatment Revenue Market Share, 2018-2029
Figure 35. By Application, Global Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)
Figure 36. By Application, Global Dermatomyositis Treatment Sales Volume Market Share, 2018-2029
Figure 37. By Application, Global Dermatomyositis Treatment Price, 2018-2029, (US$/Unit)
Figure 38. By Region, Global Dermatomyositis Treatment Revenue Market Share, 2018-2029
Figure 39. By Region, Global Dermatomyositis Treatment Sales Volume Market Share, 2018-2029
Figure 40. North America Dermatomyositis Treatment Revenue & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, North America Dermatomyositis Treatment Revenue Market Share, 2022
Figure 42. Europe Dermatomyositis Treatment Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, Europe Dermatomyositis Treatment Revenue Market Share, 2022
Figure 44. Asia Pacific Dermatomyositis Treatment Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country/Region, Asia Pacific Dermatomyositis Treatment Revenue Market Share, 2022
Figure 46. South America Dermatomyositis Treatment Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country, South America Dermatomyositis Treatment Revenue Market Share, 2022
Figure 48. Middle East & Africa Dermatomyositis Treatment Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. U.S. Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)
Figure 50. By Company, U.S. Dermatomyositis Treatment Market Share, 2022
Figure 51. By Type, U.S. Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 52. By Application, U.S. Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 53. Europe Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)
Figure 54. By Company, Europe Dermatomyositis Treatment Market Share, 2022
Figure 55. By Type, Europe Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 56. By Application, Europe Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 57. China Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)
Figure 58. By Company, China Dermatomyositis Treatment Market Share, 2022
Figure 59. By Type, China Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 60. By Application, China Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 61. Japan Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)
Figure 62. By Company, Japan Dermatomyositis Treatment Market Share, 2022
Figure 63. By Type, Japan Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 64. By Application, Japan Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 65. South Korea Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)
Figure 66. By Company, South Korea Dermatomyositis Treatment Market Share, 2022
Figure 67. By Type, South Korea Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 68. By Application, South Korea Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 69. Southeast Asia Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)
Figure 70. By Company, Southeast Asia Dermatomyositis Treatment Market Share, 2022
Figure 71. By Type, Southeast Asia Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 72. By Application, Southeast Asia Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 73. India Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)
Figure 74. By Company, India Dermatomyositis Treatment Market Share, 2022
Figure 75. By Type, India Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 76. By Application, India Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 77. Middle East & Asia Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)
Figure 78. By Company, Middle East & Asia Dermatomyositis Treatment Market Share, 2022
Figure 79. By Type, Middle East & Asia Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 80. By Application
Research Methodology:
Dermatomyositis Treatment Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|